VAN ECK ASSOCIATES CORP - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 438 filers reported holding REPLIGEN CORP in Q4 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
VAN ECK ASSOCIATES CORP ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2023$8,675
+9.2%
54,552
-2.9%
0.02%
+11.8%
Q2 2023$7,944
-22.4%
56,163
-7.6%
0.02%
-26.1%
Q1 2023$10,238
-7.0%
60,807
-6.5%
0.02%
-17.9%
Q4 2022$11,008
-99.9%
65,013
+34.5%
0.03%
+3.7%
Q3 2022$9,047,000
+852.3%
48,353
+727.0%
0.03%
+800.0%
Q2 2022$950,000
-22.3%
5,847
-10.0%
0.00%0.0%
Q1 2022$1,222,000
+13.3%
6,495
+59.5%
0.00%
+50.0%
Q4 2021$1,079,000
+8.7%
4,073
+18.5%
0.00%0.0%
Q3 2021$993,000
+44.1%
3,437
-0.5%
0.00%0.0%
Q2 2021$689,000
+6.8%
3,453
+4.1%
0.00%0.0%
Q1 2021$645,0003,3160.00%
Other shareholders
REPLIGEN CORP shareholders Q4 2022
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders